Equities

Medlive Technology Co Ltd

Medlive Technology Co Ltd

Actions
Health CareHealth Care Providers
  • Price (HKD)12.12
  • Today's Change-0.12 / -0.98%
  • Shares traded128.50k
  • 1 Year change-65.52%
  • Beta--
Data delayed at least 15 minutes, as of Aug 15 2022 04:59 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • 2192:HKG trading volume exceeds daily average by +58.86%
  • 2192:HKG price moved over -1.16% to 11.98

Key statistics

On Monday, Medlive Technology Co Ltd (2192:HKG) closed at 12.12, 76.42% above the 52 week low of 6.87 set on Mar 29, 2022.
52-week range
Today
6.87Mar 29 202247.00Nov 26 2021
Markit short selling activity
Low
Med
High
Open12.24
High12.38
Low12.10
Bid12.10
Offer12.12
Previous close12.24
Average volume627.75k
Shares outstanding715.59m
Free float166.07m
P/E (TTM)132.86
Market cap7.14bn HKD
EPS (TTM)0.0751
HKD
Annual div (ADY)0.0209
HKD
Annual div yield (ADY)0.17%
Div ex-dateJun 14 2022
Div pay-dateJul 11 2022
Data delayed at least 15 minutes, as of Aug 15 2022 04:59 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.